Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardica
Cardica's C-Port xA Anastomosis System receives European CE Mark approval
August 18th, 2006
Cardica, Inc., (CRDC) announced that it has received European CE Mark (Conformite Europeenne) approval for the C-Port xA Distal Anastomosis System for venous and arterial indications. The C-Port xA system is the next generation of the C-Port system, which automates the attachment, or anastomosis, of a bypass graft vessel and target artery downstream of the narrowed or occluded coronary artery in coronary artery bypass graft (CABG) surgery. Cardica's devices provide surgeons with a fast, reliable, automated alternative to a hand-sewn anastomosis. "We believe that the C-Port xA system offers surgeons automated, predictable and compliant anastomoses....
Source: Biotech Law Weekly (2006-08-18)
|
